Loss of p53 Causes Stochastic Aberrant X-Chromosome Inactivation and Female-Specific Neural Tube Defects
Alex R.D. Delbridge,
Andrew J. Kueh,
Francine Ke,
Natasha M. Zamudio,
Farrah El-Saafin,
Natasha Jansz,
Gao-Yuan Wang,
Megan Iminitoff,
Tamara Beck,
Sue Haupt,
Yifang Hu,
Rose E. May,
Lachlan Whitehead,
Lin Tai,
William Chiang,
Marco J. Herold,
Ygal Haupt,
Gordon K. Smyth,
Tim Thomas,
Marnie E. Blewitt,
Andreas Strasser,
Anne K. Voss
Affiliations
Alex R.D. Delbridge
Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3052, Australia; Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia
Andrew J. Kueh
Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3052, Australia; Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia
Francine Ke
Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3052, Australia; Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia
Natasha M. Zamudio
Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3052, Australia
Farrah El-Saafin
Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3052, Australia; Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia
Natasha Jansz
Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3052, Australia; Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia
Gao-Yuan Wang
Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3052, Australia; College of Life Science, Zhejiang University, Hangzhou 310058, China
Megan Iminitoff
Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3052, Australia
Tamara Beck
Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3052, Australia
Sue Haupt
Tumour Suppression Laboratory, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Department of Clinical Pathology, The University of Melbourne, Parkville, VIC 3010, Australia
Yifang Hu
Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3052, Australia
Rose E. May
Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3052, Australia
Lachlan Whitehead
Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3052, Australia; Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia
Lin Tai
Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3052, Australia
William Chiang
Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3052, Australia; Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia
Marco J. Herold
Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3052, Australia; Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia
Ygal Haupt
Tumour Suppression Laboratory, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia
Gordon K. Smyth
Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3052, Australia; School of Mathematics and Statistics, The University of Melbourne, Melbourne, VIC, Australia
Tim Thomas
Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3052, Australia; Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia
Marnie E. Blewitt
Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3052, Australia; Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia; Corresponding author
Andreas Strasser
Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3052, Australia; Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia; Corresponding author
Anne K. Voss
Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3052, Australia; Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia; Corresponding author
Summary: Neural tube defects (NTDs) are common birth defects in humans and show an unexplained female bias. Female mice lacking the tumor suppressor p53 display NTDs with incomplete penetrance. We found that the combined loss of pro-apoptotic BIM and p53 caused 100% penetrant, female-exclusive NTDs, which allowed us to investigate the female-specific functions of p53. We report that female p53−/− embryonic neural tube samples show fewer cells with inactive X chromosome markers Xist and H3K27me3 and a concomitant increase in biallelic expression of the X-linked genes, Huwe1 and Usp9x. Decreased Xist and increased X-linked gene expression was confirmed by RNA sequencing. Moreover, we found that p53 directly bound response elements in the X chromosome inactivation center (XIC). Together, these findings suggest p53 directly activates XIC genes, without which there is stochastic failure in X chromosome inactivation, and that X chromosome inactivation failure may underlie the female bias in neural tube closure defects. : The molecular mechanisms underlying the female bias of neural tube defects are currently unclear. Delbridge et al. present evidence that p53 is required for normal Xist expression and X chromosome inactivation and show in two models that partial failure of X chromosome inactivation is associated with female-biased neural tube defects. Keywords: female-specific neural tube defects, X-chromosome inactivation, p53, Xist, Ftx, Tsix, biallelic expression, BIM, BCL2L11, SMCHD1